• Je něco špatně v tomto záznamu ?

The involvement of sirtuin 1 and heme oxygenase 1 in the hepatoprotective effects of quercetin against carbon tetrachloride-induced sub-chronic liver toxicity in rats

MK. Kemelo, A. Pierzynová, N. Kutinová Canová, T. Kučera, H. Farghali,

. 2017 ; 269 (-) : 1-8. [pub] 20170325

Jazyk angličtina Země Irsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc17023173

The present study was designed to evaluate the therapeutic potential of quercetin in a sub-chronic model of hepatotoxicity. The roles of putative antioxidant enzymes, sirtuin 1 (SIRT1) and heme oxygenase 1 (HO-1), in hepatoprotection were also addressed. Sub-chronic liver injury was induced in rats by intraperitoneal administration of 0.5 ml/kg carbon tetrachloride (CTC), once every 3 days, for 2 weeks. Some CTC rats were concurrently treated with 100 mg/kg quercetin, intragastrically, once every day, for 2 weeks. The effects of these drugs in the liver were evaluated by biochemical, histological, immunohistochemical and molecular biological studies. CTC triggered oxidative damage to the liver as unanimously shown by altered biochemical parameters and liver morphology. Furthermore, CTC highly upregulated HO-1 and SIRT1 expression levels. Concomitant treatment of rats with quercetin downregulated SIRT1 expression and ameliorated the hepatotoxic effects of CTC. However, quercetin did not have any significant effect on HO-1 expression and bilirubin levels. Collectively, these results suggest that the antioxidant and cytoprotective effects of quercetin in CTC treated rats were SIRT1 mediated and less dependent on HO-1. Thus, pharmacologic modulation of SIRT1 could provide a logic therapeutic approach in sub-chronic hepatotoxicity.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17023173
003      
CZ-PrNML
005      
20180605125039.0
007      
ta
008      
170720s2017 ie f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.cbi.2017.03.014 $2 doi
035    __
$a (PubMed)28347707
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ie
100    1_
$a Kemelo, Mighty Kgalalelo $u Institute of Pharmacology, 1st Faculty of Medicine, Charles University and General University Hospital in Prague, Czech Republic. Electronic address: mighty.kemelo@lf1.cuni.cz. $7 xx0225018
245    14
$a The involvement of sirtuin 1 and heme oxygenase 1 in the hepatoprotective effects of quercetin against carbon tetrachloride-induced sub-chronic liver toxicity in rats / $c MK. Kemelo, A. Pierzynová, N. Kutinová Canová, T. Kučera, H. Farghali,
520    9_
$a The present study was designed to evaluate the therapeutic potential of quercetin in a sub-chronic model of hepatotoxicity. The roles of putative antioxidant enzymes, sirtuin 1 (SIRT1) and heme oxygenase 1 (HO-1), in hepatoprotection were also addressed. Sub-chronic liver injury was induced in rats by intraperitoneal administration of 0.5 ml/kg carbon tetrachloride (CTC), once every 3 days, for 2 weeks. Some CTC rats were concurrently treated with 100 mg/kg quercetin, intragastrically, once every day, for 2 weeks. The effects of these drugs in the liver were evaluated by biochemical, histological, immunohistochemical and molecular biological studies. CTC triggered oxidative damage to the liver as unanimously shown by altered biochemical parameters and liver morphology. Furthermore, CTC highly upregulated HO-1 and SIRT1 expression levels. Concomitant treatment of rats with quercetin downregulated SIRT1 expression and ameliorated the hepatotoxic effects of CTC. However, quercetin did not have any significant effect on HO-1 expression and bilirubin levels. Collectively, these results suggest that the antioxidant and cytoprotective effects of quercetin in CTC treated rats were SIRT1 mediated and less dependent on HO-1. Thus, pharmacologic modulation of SIRT1 could provide a logic therapeutic approach in sub-chronic hepatotoxicity.
650    _2
$a alanintransaminasa $x krev $7 D000410
650    _2
$a zvířata $7 D000818
650    _2
$a aspartátaminotransferasy $x krev $7 D001219
650    _2
$a bilirubin $x krev $7 D001663
650    _2
$a otrava chloridem uhličitým $x metabolismus $x patologie $x prevence a kontrola $7 D002252
650    _2
$a down regulace $x účinky léků $7 D015536
650    _2
$a hemoxygenasa-1 $x metabolismus $7 D051547
650    _2
$a imunohistochemie $7 D007150
650    _2
$a játra $x metabolismus $x patologie $7 D008099
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a ochranné látky $x farmakologie $7 D020011
650    _2
$a quercetin $x farmakologie $7 D011794
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a potkani Wistar $7 D017208
650    _2
$a sirtuin 1 $x metabolismus $7 D056564
650    _2
$a upregulace $x účinky léků $7 D015854
655    _2
$a časopisecké články $7 D016428
700    1_
$a Pierzynová, Aneta $7 xx0224306 $u Institute of Histology and Embryology, 1st Faculty of Medicine, Charles University and General University Hospital in Prague, Czech Republic.
700    1_
$a Kutinová Canová, Nikolina $u Institute of Pharmacology, 1st Faculty of Medicine, Charles University and General University Hospital in Prague, Czech Republic.
700    1_
$a Kučera, Tomáš $u Institute of Histology and Embryology, 1st Faculty of Medicine, Charles University and General University Hospital in Prague, Czech Republic.
700    1_
$a Farghali, Hassan $u Institute of Pharmacology, 1st Faculty of Medicine, Charles University and General University Hospital in Prague, Czech Republic.
773    0_
$w MED00002111 $t Chemico-biological interactions $x 1872-7786 $g Roč. 269, č. - (2017), s. 1-8
856    41
$u https://pubmed.ncbi.nlm.nih.gov/28347707 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20170720 $b ABA008
991    __
$a 20180605125241 $b ABA008
999    __
$a ok $b bmc $g 1238854 $s 984086
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 269 $c - $d 1-8 $e 20170325 $i 1872-7786 $m Chemico-biological interactions $n Chem Biol Interact $x MED00002111
LZP    __
$a Pubmed-20170720

Najít záznam

Citační ukazatele

Možnosti archivace